Stephens Sees Sustainable Growth for Establishment Labs Holdings Inc. (ESTA) Over the Coming Years

Establishment Labs Holdings Inc. (NASDAQ:ESTA) is among the 10 Fastest Growing Mid Cap Stocks to Buy Now.

Establishment Labs Holdings Inc. (NASDAQ:ESTA) is among the fastest growing stocks.

TheFly reported on February 25 that Stephens raised the price target for ESTA to $90 from $85 and kept an Overweight rating on the stock. According to the firm, the company's expanding U.S. market share, new product revenue, and strong momentum in direct international markets should support long-term gains in profitability and drive the company to sustainable growth above 25% over the coming years.

Additionally, Establishment Labs Holdings Inc. (NASDAQ:ESTA) reported $64.62 million in revenue for the fourth quarter on February 24, which was slightly higher than the $64.12 million consensus expectation. Strong demand from patients and surgeons has been the company's driving force since 2025. Its Preserve product has become widely accepted in foreign markets, leading to an increase in procedure volumes and revenues.

The company is attracting a wider range of customers by providing patients with less anesthesia and quicker recovery with the introduction of a new category of tissue-preserving, minimally invasive solutions. In addition to boosting ESTA's overall global business expansion, this combination of innovation and market acceptance is helping to significantly increase the number of plastic surgery treatments.

Establishment Labs Holdings Inc. (NASDAQ:ESTA) is a global medical technology company specializing in breast aesthetics and reconstruction. It develops and markets silicone breast implants and related products, focusing on safety, innovation, and advanced manufacturing to serve plastic surgeons and patients worldwide.

While we acknowledge the potential of ESTA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 14 Best GARP Stocks to Buy According to Analysts and 14 Best Affordable Dividend Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey on Google News.